Array BioPharma Inc - Product Pipeline Review

Global Markets Direct’s, ‘Array BioPharma Inc - Product Pipeline Review - 2016’, provides an overview of the Array BioPharma Inc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Array BioPharma Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Array BioPharma Inc

The report provides overview of Array BioPharma Inc including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Array BioPharma Inc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Array BioPharma Inc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Array BioPharma Inc’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Array BioPharma Inc

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Array BioPharma Inc’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Introduction 6

Global Markets Direct Report Coverage 6

Array BioPharma ...

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Introduction 6

Global Markets Direct Report Coverage 6

Array BioPharma Inc Snapshot 7

Array BioPharma Inc Overview 7

Key Facts 7

Array BioPharma Inc - Research and Development Overview 8

Key Therapeutic Areas 8

Array BioPharma Inc - Pipeline Review 11

Pipeline Products by Stage of Development 11

Pipeline Products - Monotherapy 12

Pipeline Products - Combination Treatment Modalities 13

Pipeline Products - Partnered Products 14

Partnered Products/Combination Treatment Modalities 15

Pipeline Products - Out-Licensed Products 16

Out-Licensed Products/Combination Treatment Modalities 17

Array BioPharma Inc - Pipeline Products Glance 19

Array BioPharma Inc - Late Stage Pipeline Products 19

Pre-Registration Products/Combination Treatment Modalities 19

Phase III Products/Combination Treatment Modalities 20

Array BioPharma Inc - Clinical Stage Pipeline Products 21

Phase II Products/Combination Treatment Modalities 21

Phase I Products/Combination Treatment Modalities 22

Array BioPharma Inc - Early Stage Pipeline Products 23

Preclinical Products/Combination Treatment Modalities 23

Discovery Products/Combination Treatment Modalities 24

Array BioPharma Inc - Drug Profiles 25

AR-00457679 - Drug Profile 25

Product Description 25

Mechanism Of Action 25

R&D Progress 25

AR-460770 - Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

AR-523 - Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

AR-786 - Drug Profile 28

Product Description 28

Mechanism Of Action 28

R&D Progress 28

ARRY-111 - Drug Profile 29

Product Description 29

Mechanism Of Action 29

R&D Progress 29

ARRY-382 - Drug Profile 30

Product Description 30

Mechanism Of Action 30

R&D Progress 30

ARRY-797 - Drug Profile 32

Product Description 32

Mechanism Of Action 32

R&D Progress 32

ARRY-954 - Drug Profile 35

Product Description 35

Mechanism Of Action 35

R&D Progress 35

binimetinib - Drug Profile 36

Product Description 36

Mechanism Of Action 36

R&D Progress 36

binimetinib + encorafenib - Drug Profile 45

Product Description 45

Mechanism Of Action 45

R&D Progress 45

encorafenib - Drug Profile 49

Product Description 49

Mechanism Of Action 49

R&D Progress 49

Small Molecules for Inflammation - Drug Profile 53

Product Description 53

Mechanism Of Action 53

R&D Progress 53

Array BioPharma Inc - Pipeline Analysis 54

Array BioPharma Inc - Pipeline Products by Target 54

Array BioPharma Inc - Pipeline Products by Route of Administration 56

Array BioPharma Inc - Pipeline Products by Molecule Type 57

Array BioPharma Inc - Pipeline Products by Mechanism of Action 58

Array BioPharma Inc - Dormant Projects 60

Array BioPharma Inc - Discontinued Pipeline Products 61

Discontinued Pipeline Product Profiles 61

ARRY-797 61

AZD-8330 61

binimetinib 61

GDC-0425 62

GDC-0994 62

Mutant cKIT Inhibitor for GIST 62

rabusertib 62

selumetinib sulfate 62

Array BioPharma Inc - Company Statement 63

Array BioPharma Inc - Locations And Subsidiaries 69

Head Office 69

Other Locations & Subsidiaries 69

Appendix 70

Methodology 70

Coverage 70

Secondary Research 70

Primary Research 70

Expert Panel Validation 70

Contact Us 70

Disclaimer 71

List of Tables

List of Tables

Array BioPharma Inc, Key Facts 7

Array BioPharma Inc - Pipeline by Indication, 2016 9

Array BioPharma Inc - Pipeline by Stage ...

List of Tables

Array BioPharma Inc, Key Facts 7

Array BioPharma Inc - Pipeline by Indication, 2016 9

Array BioPharma Inc - Pipeline by Stage of Development, 2016 11

Array BioPharma Inc - Monotherapy Products in Pipeline, 2016 12

Array BioPharma Inc - Combination Treatment Modalities in Pipeline, 2016 13

Array BioPharma Inc - Partnered Products in Pipeline, 2016 14

Array BioPharma Inc - Partnered Products/ Combination Treatment Modalities, 2016 15

Array BioPharma Inc - Out-Licensed Products in Pipeline, 2016 16

Array BioPharma Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016 17

Array BioPharma Inc - Pre-Registration, 2016 19

Array BioPharma Inc - Phase III, 2016 20

Array BioPharma Inc - Phase II, 2016 21

Array BioPharma Inc - Phase I, 2016 22

Array BioPharma Inc - Preclinical, 2016 23

Array BioPharma Inc - Discovery, 2016 24

Array BioPharma Inc - Pipeline by Target, 2016 55

Array BioPharma Inc - Pipeline by Route of Administration, 2016 56

Array BioPharma Inc - Pipeline by Molecule Type, 2016 57

Array BioPharma Inc - Pipeline Products by Mechanism of Action, 2016 59

Array BioPharma Inc - Dormant Developmental Projects,2016 60

Array BioPharma Inc - Discontinued Pipeline Products, 2016 61

Array BioPharma Inc, Other Locations 69

List of Figures

List of Figures

Array BioPharma Inc - Pipeline by Top 10 Indication, 2016 9

Array BioPharma Inc - Pipeline by Stage of Development, 2016 11 ...

List of Figures

Array BioPharma Inc - Pipeline by Top 10 Indication, 2016 9

Array BioPharma Inc - Pipeline by Stage of Development, 2016 11

Array BioPharma Inc - Monotherapy Products in Pipeline, 2016 12

Array BioPharma Inc - Combination Treatment Modalities in Pipeline, 2016 13

Array BioPharma Inc - Partnered Products in Pipeline, 2016 14

Array BioPharma Inc - Out-Licensed Products in Pipeline, 2016 16

Array BioPharma Inc - Pipeline by Top 10 Target, 2016 54

Array BioPharma Inc - Pipeline Route of Administration, 2016 56

Array BioPharma Inc - Pipeline by Molecule Type, 2016 57

Array BioPharma Inc - Pipeline Products by Top 10 Mechanism of Action, 2016 58

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports